John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 6,670 shares at $160.90 ($1.1M) on 2018-03-05, disclosed to the SEC on 2018-03-06.
Open-market sale of $1.1M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.90 | 3,335 | $537K | 50.0% |
| 2 | $160.90 | 3,335 | $537K | 50.0% |
| Total | $160.90 avg | 6,670 | $1.1M | 100% |
| Filing → |
| LGND | SELL | 2025-11-12 | $1.7M | — | Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |